Prosecution of the Tuschl II patent series that include composition of matter for siRNA, the molecules that mediate RNAi. The Tuschl II patent family members is exclusively licensed to Alnylam for RNAi therapeutics on an internationally basis through an contract with Max Planck Development GmbH, the licensing agent for the Max Planck Society.D., Senior Vice President, Chief Business Officer at Alnylam. ‘We believe that our unparalleled intellectual property estate will defend the innovative medications we progress to the market as part of our 'Alnylam 5×15' product strategy.Some of these guidelines are general, and require a few of your own creativity and initiative to implement. You can begin creating generosity and the optimal relationship knowledge for yourself and your loved ones by simply asking the query ‘how.’ How do i show my family friends my love and appreciation? How do i reach those in need around me? Just how do we make this relationship the best one yet?. ACR REF Clinician Scholar Education Award for rheumatology health professionals At the core of the American College of Rheumatology Research and Education Foundation’s mission is to attract the very best and brightest trainees right into a career in rheumatology. To do this, the REF comes with an considerable portfolio of awards and grants offering support during critical profession stages.